SA Business Journal: San Antonio drug developer obtains key patent approval in path to market

San Antonio-based Rapamycin Holdings Inc. has secured U.S. patent approval for the pharmaceutical formulation of its eRapa compound — a critical benchmark in the company’s growth. 

Read the full story at the San Antonio Business Journal

Share This Article!
Article categories: In the News